Biologic Markers of Antibiotic-Refractory Lyme Arthritis in Human: A Systematic Review
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-6382
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Biologic Markers of Antibiotic-Refractory Lyme Arthritis in Human: A Systematic Review ; day:30 ; month:11 ; year:2018 ; pages:1-18
Infectious diseases and therapy ; (30.11.2018), 1-18
- Urheber
-
Badawi, Alaa
Arora, Paul
Brenner, Darren
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40121-018-0223-0
- URN
-
urn:nbn:de:101:1-2019011723391668915082
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Badawi, Alaa
- Arora, Paul
- Brenner, Darren
- SpringerLink (Online service)
Ähnliche Objekte (12)
Lyme arthritis in Southern Norway - an endemic area for Lyme Borreliosis
Lyme-Arthritis : Von der Borrelien-Infektion zur postinfektiösen Arthritis
Biologic predictors of clinical improvement in rituximab-treated refractory myositis
Administration costs of intravenous biologic drugs for rheumatoid arthritis
Biologic monotherapy in the biologic naïve patient with rheumatoid arthritis (RA): results from an observational study
Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis
Was führt zur Antibiotika-refraktären Lyme-Arthritis bei Kindern?
Infliximab in chronic non-infectious paediatric uveitis refractory to previous biologic therapy
Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America
Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?
Persistent Lyme Empiric Antibiotic Study Europe (PLEASE) - design of a randomized controlled trial of prolonged antibiotic treatment in patients with persistent symptoms attributed to Lyme borreliosis
Klinische und serologische Verlaufskontrollen bei 149 Patienten mit Lyme-Borreliose (Lyme-Arthritis, Erythema migrans, Acrodermatitis chronica atrophicans)
Lyme arthritis in Southern Norway - an endemic area for Lyme Borreliosis
Lyme-Arthritis : Von der Borrelien-Infektion zur postinfektiösen Arthritis
Biologic predictors of clinical improvement in rituximab-treated refractory myositis
Administration costs of intravenous biologic drugs for rheumatoid arthritis
Biologic monotherapy in the biologic naïve patient with rheumatoid arthritis (RA): results from an observational study
Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis
Was führt zur Antibiotika-refraktären Lyme-Arthritis bei Kindern?
Infliximab in chronic non-infectious paediatric uveitis refractory to previous biologic therapy
Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America
Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?
Persistent Lyme Empiric Antibiotic Study Europe (PLEASE) - design of a randomized controlled trial of prolonged antibiotic treatment in patients with persistent symptoms attributed to Lyme borreliosis
Klinische und serologische Verlaufskontrollen bei 149 Patienten mit Lyme-Borreliose (Lyme-Arthritis, Erythema migrans, Acrodermatitis chronica atrophicans)
Lyme arthritis in Southern Norway - an endemic area for Lyme Borreliosis
Lyme-Arthritis : Von der Borrelien-Infektion zur postinfektiösen Arthritis
Biologic predictors of clinical improvement in rituximab-treated refractory myositis
Administration costs of intravenous biologic drugs for rheumatoid arthritis
Biologic monotherapy in the biologic naïve patient with rheumatoid arthritis (RA): results from an observational study
Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis
Was führt zur Antibiotika-refraktären Lyme-Arthritis bei Kindern?
Infliximab in chronic non-infectious paediatric uveitis refractory to previous biologic therapy
Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America
Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?
Persistent Lyme Empiric Antibiotic Study Europe (PLEASE) - design of a randomized controlled trial of prolonged antibiotic treatment in patients with persistent symptoms attributed to Lyme borreliosis